Figure 2.Survival analysis of breast cancer with high and low CD204 expression statuses among untreated patients, including all cases of breast cancer (A–C), luminal A (D–F), luminal B (G–I), HER2-positive (J, K), and basal-like (L–N) subtype.
Figure 2 — Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer | Aging
